68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Medullary Thyroid CancerPrositron Emission TomographyFibroblast Activation Protein InhibitorSurgery
Interventions
PROCEDURE

Surgery

Surgery is performed based on the lesion range revealed by 68Ga-TCR-FAPI PET/CT, and all 68Ga-TCR-FAPI-avid lesions are resected.

PROCEDURE

Surgery

68Ga-TCR-FAPI PET/CT identified distant metastasis or unresectable lesions, but the patient is still recommended to undergo surgery for debulking or reduce symptoms.

Trial Locations (1)

100021

RECRUITING

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
collaborator

Peking University

OTHER

collaborator

Peking University Cancer Hospital & Institute

OTHER

lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER